This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Universal Health to Report Q4 Earnings: What Do the Estimates Say?
by Zacks Equity Research
UHS' fourth-quarter earnings are likely to have benefited from growing admissions and patient days.
Select Medical Q4 Earnings Miss Estimates, Stock Down 7.2%
by Zacks Equity Research
SEM expects revenues to be between $5.4 billion and $5.6 billion, the mid-point of which implies 5.8% growth from the 2024 figure of $5.2 billion.
4 Healthcare Stocks to Buy as the Sector Stages a Comeback
by Abhinab Dasgupta
Buy healthcare stocks like WGS, THC, RIGL and ENSG for steady returns as the focus shifts to the incoming Trump administration's healthcare policies.
Why Ensign Group (ENSG) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks.com featured highlights Deckers Outdoor, Boot Barn, Addus HomeCare and The Ensign Group
by Zacks Equity Research
Deckers Outdoor, Boot Barn, Addus HomeCare and The Ensign Group have been highlighted in this Screen of The Week article.
Community Health Q4 Earnings Miss on Lower Adjusted Admissions
by Zacks Equity Research
CYH expects 2025 capital expenditures to be in the range of $350-$4000 million.
Pick These 4 Stocks With Impressive Interest Coverage Ratios
by Sumit Singh
DECK, BOOT, ADUS & ENSG's impressive interest coverage ratios highlight that these companies can withstand financial hardships.
Pediatrix Medical Gears Up for Q4 Results: What to Expect?
by Zacks Equity Research
MD's fourth-quarter results are likely to reflect declining revenues and expenses.
Can Community Health Beat Q4 Earnings on Growing Occupancy?
by Zacks Equity Research
CYH's fourth-quarter earnings are likely to have been aided by higher revenue per adjusted admission.
Zacks.com featured highlights include Tyson Foods, NetApp, NextEra Energy, The Ensign and Central Garden & Pet
by Zacks Equity Research
Tyson Foods, NetApp, NextEra Energy, The Ensign and Central Garden & Pet have been highlighted in this Screen of The Week article.
Here's Why Ensign Group (ENSG) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Bet on 5 Top-Ranked Stocks With Rising P/E
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Tyson Foods, NetApp, NextEra Energy, The Ensign Group and Central Garden & Pet.
Is Ensign Group (ENSG) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Ensign Group (ENSG) possesses solid growth attributes, which could help it handily outperform the market.
Is the Options Market Predicting a Spike in The Ensign (ENSG) Stock?
by Zacks Equity Research
Investors need to pay close attention to The Ensign (ENSG) stock based on the movements in the options market lately.
Ensign Group (ENSG) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
by Zacks Equity Research
Ensign Group (ENSG) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Humana Incurs Wider Y/Y Loss in Q4 on Decline in Membership
by Zacks Equity Research
HUM's fourth-quarter results suffer a blow due to a membership decline in Medicare stand-alone PDP, partly offset by a strong Primary Care business. It currently expects 2025 adjusted EPS to be around $16.25.
Can Tenet Healthcare Navigate Through Lower Revenues in Q4?
by Zacks Equity Research
THC's fourth-quarter results are likely to reflect growing patient admissions, utilization and patient days.
Ensign Group Shares Plunge 12% Despite Q4 Earnings Beat
by Zacks Equity Research
ENSG's fourth-quarter results gain on strong contribution from the Skilled Services unit, partly offset by the escalating cost of services. It estimates 2025 adjusted EPS to be within $6.16-$6.34.
Wall Street Analysts Believe Ensign Group (ENSG) Could Rally 26.08%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 26.1% upside potential for Ensign Group (ENSG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Why Ensign Group (ENSG) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is The Ensign Group (ENSG) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Ensign Group (ENSG) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 1.36% and 0.81%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights BioMarin, Cheesecake Factory, Leidos and The Ensign
by Zacks Equity Research
BioMarin, Cheesecake Factory, Leidos and The Ensign have been highlighted in this Screen of The Week article.
4 Stocks That Sport Impressive Interest Coverage Ratio
by Sumit Singh
BMRN, CAKE, LDOS & ENSG's impressive interest coverage ratios highlight that these companies can withstand financial hardships.
Here's Why Ensign Group (ENSG) is a Strong Growth Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.